Advertisement
Research Article

Increased Risk for Developing Major Adverse Cardiovascular Events in Stented Chinese Patients Treated with Dual Antiplatelet Therapy after Concomitant Use of the Proton Pump Inhibitor

  • Jian-Jun Zou,

    Affiliation: Division of Clinical Pharmacology, General Clinical Research Center, Nanjing Medical University Nanjing First Hospital, Nanjing, China

    X
  • Shao-Liang Chen mail,

    hongg.xie@gmail.com (HGX); chmengx126@gmail.com (SLC)

    Affiliation: Division of Cardiovascular Medicine, Department of Medicine, Nanjing Medical University Nanjing First Hospital, Nanjing, China

    X
  • Jie Tan,

    Affiliation: Division of Clinical Pharmacology, General Clinical Research Center, Nanjing Medical University Nanjing First Hospital, Nanjing, China

    X
  • Ling Lin,

    Affiliation: Division of Cardiovascular Medicine, Department of Medicine, Nanjing Medical University Nanjing First Hospital, Nanjing, China

    X
  • Ying-Ying Zhao,

    Affiliation: Division of Cardiovascular Medicine, Department of Medicine, Nanjing Medical University Nanjing First Hospital, Nanjing, China

    X
  • Hai-Mei Xu,

    Affiliation: Division of Cardiovascular Medicine, Department of Medicine, Nanjing Medical University Nanjing First Hospital, Nanjing, China

    X
  • Song Lin,

    Affiliation: Division of Cardiovascular Medicine, Department of Medicine, Nanjing Medical University Nanjing First Hospital, Nanjing, China

    X
  • Juan Zhang,

    Affiliation: Division of Cardiovascular Medicine, Department of Medicine, Nanjing Medical University Nanjing First Hospital, Nanjing, China

    X
  • Hong-Wei Fan,

    Affiliation: Division of Clinical Pharmacology, General Clinical Research Center, Nanjing Medical University Nanjing First Hospital, Nanjing, China

    X
  • Hong-Guang Xie mail

    hongg.xie@gmail.com (HGX); chmengx126@gmail.com (SLC)

    Affiliations: Division of Clinical Pharmacology, General Clinical Research Center, Nanjing Medical University Nanjing First Hospital, Nanjing, China, Central Laboratory, General Clinical Research Center, Nanjing Medical University Nanjing First Hospital, Nanjing, China, Department of Pharmacology, Nanjing Medical University School of Pharmacy, Nanjing, China

    X
  • Published: January 08, 2014
  • DOI: 10.1371/journal.pone.0084985

Reader Comments (0)

Post a new comment on this article